Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : VVUS: VIVUS INC. (NASDAQ) -- Ignore unavailable to you. Want to Upgrade?

To: RT who wrote (5708)	2/28/1998 12:10:00 PM
From: Tunica Albuginea	Read Replies (1) \| Respond to of 23519

RT, how can refills increase if there is no drug available? It will have to come from new 1st time users; but they want the drug too. TA

To: RT who wrote (5708)	3/1/1998 8:37:00 PM
From: Gene Voss	Read Replies (2) \| Respond to of 23519

RE: Refill #'s.Don't know much about this but efficacy could be addressed.I know that a considerable improvement in the formula is easily attainable.Efficacy rates approaching injectables via the transurethral technique are possible.Viagras oral will be underwhelming especially with the exaggerated hype.One other problem with psychological ED population may be a "cure" after a few doses.I would be encouraged to delete therapy after a period of successful erections.I certainly expect considerable sales of Viagra with its introduction but only the physiologically compomised patients will pay the on going cost of therapy.The fefill rate for Viagra after its 1st year will be very telling. GV